Novo investors call for dealmaking and new drugs
Source:
financialTimes
September 19, 2026 · 21:00
From the publisher
Ozempic maker is under pressure to diversify as it prepares to face shareholders on Monday
The original article opens on the publisher's website.
More from General
View topic →What to Do If You’re Laid Off and Too Young for Medicare
nytimes
Sep 20, 2026 · 02:01
Mistakes? We’ve Made a Few
nytimes
Sep 20, 2026 · 02:00
As the Rich Buy Bigger Boats, Private Equity Is Investing in the Booming Marina Business
nytimes
Sep 20, 2026 · 02:00
NPR's College Podcast Challenge is back for 2026
nprNews
Sep 20, 2026 · 02:00
How the NPR College Podcast Challenge changed lives
nprNews
Sep 20, 2026 · 02:00